HIV

Long-acting HIV treatments could be the key to diminishing HIV cases and getting Medicaid beneficiaries the help they need.

This is the latest funding announcement made by the Health Resources and Services Administration’s Enhancing Maternal Health Initiative.

Younger transgender and gender diverse individuals see a greater stigma around PrEP, but experts are still unsure why.

Here’s what you missed this week on Managed Healthcare Executive.

The St. Louis-based center will serve as a base where researchers and public health experts can fight the HIV epidemic together.

This is good news for developing an HIV vaccine because previous research had indicated it could take years for these antibodies to appear.

Women with HIV are more affected by stigma, gender inequality and socioeconomic status when compared to men with HIV.

A separate trial is ongoing of Sunlenca as pre-exposure prophylaxis (PrEP) for men with topline data expected in late 2024 or early 2025.

This is the first new recommendation from the American Academy of Pediatrics since the AIDS epidemic began in the 1980s.

Healthcare providers and community leaders won’t need a green thumb to implement these changes.

The efforts to prevent one disease increased another, likely due to the lack of methadone and sterile needles.

PrEP could work for women too, but there's a gap in HIV rates among this demographic, especially Black women. Outside of PrEP's proven effectiveness, the below facts suggest the need for better promotion and more options.

This marks the first documented HIV transmission through cosmetic services using needles.

Judith Currier, M.D., M.Sc., ACTG Chair, discussed the trial, how it’s different than previous research and the connotations surrounding the “cure” to HIV.

Although newly acquired HIV infection rates are low among people who are incarcerated, 95% of at-risk inmates may engage in unsafe behavior after their release, a study shows.

How COVID-19 became a jumping off point for HIV vaccine conspiracies.

People with HIV who smoke have a life expectancy 12.3 years shorter than non-smokers.

Although there is a suspected connection between malaria and HIV, no malaria control strategies have been developed specifically for people living with HIV.

Results based on REPRIEVE study.

Adolescent uptake levels of PrEP are low among adolescents ages 16-24 years old.

Biktarvy can now be used to treat people with HIV who have a known or suspected M184V/I mutation, a common form of treatment resistance.

Duke researchers tested a program that involves hair stylists in raising awareness, possible uptake of HIV preexposure prophylaxis (PrEP) among Black women, a group that is disproportionately affected by new HIV infections.

Different levels of risk for HIV exist in the different subtypes of intellectual and developmental disabilities.

A small trial that combined the anticancer drug Zolinza with an immunotherapy had a modest impact on antiviral activity in patients with HIV. Researchers are hoping better approaches can be found to coax HIV out of hiding.

It’s likely droughts will become more common due to climate change.